Old spontaneously hypertensive rats gather together typical features of human chronic left-ventricular dysfunction with preserved ejection fraction

Journal of Hypertension

Volumn 32, Issue 6, 2014, Pages 1307-1316

  Marzak, Halim ^a   Ayme Dietrich, Estelle ^a   Lawson, Roland ^a   Mokni, Walid ^a   Combe, Roy ^b   Becker, Julien ^b   Fertak, Lahcen El ^b   Champy, Marie France ^b   Monassier, Laurent ^a,b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b INSTITUT CLINIQUE DE LA SOURIS   (France)

Author keywords

cardiac hypertrophy; diastole; ejection fraction; hypertension; ischemia; nicardipine; spontaneously hypertensive rat

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); AGUETTANT; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 3; MYOSIN HEAVY CHAIN BETA; NICARDIPINE; UNCLASSIFIED DRUG; COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CHRONIC DISEASE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIASTOLE; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENDOPLASMIC RETICULUM; GENE EXPRESSION; HEART AFTERLOAD; HEART CATHETERIZATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART RATE; HISTOPATHOLOGY; HYPERTENSION; LUNG CONGESTION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; ST SEGMENT; ZYMOGRAPHY; AGING; ANIMAL; DISEASE MODEL; DOPPLER FLOWMETRY; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART CONTRACTION; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; HUMAN; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

AGING; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; COLLAGEN; DIASTOLE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FIBROSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART FAILURE; HEART RATE; HEART VENTRICLES; HUMANS; MALE; MYOCARDIAL CONTRACTION; RATS; RATS, INBRED SHR; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84900335785     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000159     Document Type: Article

References (37)

1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 33:1787-1847.
2. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al the EuroHeart Failure survey programme a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003; 24:442-463.
3. Lenzen MJ, Scholte op Reimer WJ, Boersma E, Vantrimpont PJ, Follath F, Swedberg K, et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004; 25:1214-1220.
4. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARMPreserved Trial. Lancet 2003; 362:777-781.
5. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008; 359:2456-2467.
6. Gomes AC, Falcão-Pires I, Pires AL, Brás-Silva C, Leite-Moreira AF. Rodent models of heart failure: an updated review. Heart Fail Rev 2013; 18:219-249.
7. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994; 89:345-354.
8. Ono K, Masuyama T, Yamamoto K, Doi R, Sakata Y, Nishikawa N, et al. Echo Doppler assessment of left ventricular function in rats with hypertensive hypertrophy. J Am Soc Echocardio 2002; 15:109-117.
9. Slama M, Ahn J, Varagic J, Susic D, Frohlich ED. Long-term left ventricular echocardiographic follow-up of SHR and WKY rats: effects of hypertension and age. Am J Physiol Heart Circ Physio 2004; 286: 181-185.
10. Zuurbier CJ, Keijzers PJM, Koeman A, Van Wezel HB, Hollmann MW. Anesthesia's effects on plasma glucose and insulin and cardiac hexokinase at similar hemodynamics and without major surgical stress in fed rats. Anesth Analg 2008; 106:135-142.
11. Stein AB, Tiwari S, Thomas P, Hunt G, Levent C, Stoddart MF, et al. Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res Cardiol 2007; 102:28-41.
12. Hu X, Beeton C. Detection of functional matrix metalloproteinases by zymography. J Vis Exp 2010; 45:e2445.
13. Slama M, Ahn J, Peltier M, Maizel J, Chemla D, Varagic J, et al. Validation of echographic and Doppler indexes of left ventricular relaxation in adult hypertensive and normotensive rats. Am J Physiol Heart Circ Physiol 2005; 289:1131-1136.
14. Judy WV, Farrell SK. Arterial baroreceptor reflex control of sympathetic nerve activity in the spontaneously hypertensive rat. Hypertension 1979; 1:605-614.
15. Li D, Wang L, Lee CW, Dawson TA, Paterson DJ. Noradrenergic cell specific gene transfer with neuronal nitric oxide synthase reduces cardiac sympathetic neurotransmission in hypertensive rats. Hypertension 2007; 50:69-74.
16. Cingolani OH, Yang XP, Cavasin MA, Carretero OA. Increased systolic performance with diastolic dysfunction in adult spontaneously hypertensive rats. Hypertension 2003; 41:249-254.
17. Slama M, Susic D, Varagic J, Ahn J, Frohlich ED. Echocardiographic measurement of cardiac output in rats. Am J Physiol Heart Circ Physio 2003; 284: 691-697.
18. Dupont S, Maizel J, Mentaverri R, Chillon JM, Six I, Giummelly P, et al the onset of left ventricular diastolic dysfunction in SHR rats is not related to hypertrophy or hypertension. Am J Physiol 2012; 302:1524-1532.
19. Perlini S, Chung ES, Aurigemma GP, Meyer TE. Alterations in early filling dynamics predict the progression of compensated pressure overload hypertrophy to heart failure better than abnormalities in midwall systolic shortening. Clin Exp Hypert 2013; 35:401-411.
20. Smith TL, Hutchins PM. Anesthetic effects on hemodynamics of spontaneously hypertensive and Wistar-Kyoto rats. Am J Physiol Heart Circ Physiol 1980; 238:539-544.
21. Janssen BJ, De Celle T, Debets JJ, Brouns AE, Callahan MF, Smith TL. Effects of anesthetics on systemic hemodynamics in mice. Am J Physiol Heart Circ Physiol 2004; 287:1618-1624.
22. Moreo A, Ambrosio G, De Chiara B, Tran T, Mauri F, Raman SV. Influence of myocardial fibrosis on left ventricular diastolic function. Noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2009; 2:437-443.
23. Ellims AH, Iles LM, Ling L, Hare JL, Kaye DM, Taylor AJ, et al. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction. J Cardiovasc Magn Res 2012; 14:76.
24. Chang SA, Lee SC, Choe YH, Hahn HJ, Jang SY, Park SJ, et al. Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 2012; 28:133-140.
25. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A, et al. Diastolic heart failure. Evidence for increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007; 115:888-895.
26. Gonzales A, Lopez B, Querejeta R, Zubillaga E, Echeverria T, Diez J. Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction. Hypertension 2010; 55:1418-1424.
27. Reed AL, Tanaka A, Sorescu D, Liu H, Jeong EM, Sturdy M, et al. Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse. Am J Physiol Heart Circ Physiol 2011; 301:H824-H831.
28. Ichihara S, Noda A, Nagata K, Obata K, Xu J, Ichihara G, et al. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure. Cardiovasc Res 2006; 69:726-735.
29. Bing OH, Conrad CH, Boluyt MO, Robinson KG, Brooks WW. Studies of prevention, treatment and mechanisms of heart failure in the aging spontaneously hypertensive rat. Heart Fail Rev 2002; 7:71-88.
30. Boluyt MO, Bing OHL. Matrix gene expression and decompensated heart failure: the aged SHR model. Cardiovasc Res 2000; 46:239-249.
31. Tozzi R, Palladini G, Fallarini S, Nano R, Gatti C, Presotto C, et al. Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy. Am J Hypert 2007; 20:663-669.
32. Belichard P, Pruneau D, Brown NL, Salzmann JL, Rouet R. Hypertensive myocardial hypertrophy an rhythm disorders: 2 possible origins. Arch Mal Coeur Vaiss 1989; 82:1303-1308.
33. Bing OH, Ngo HQ, Humphries DE, Robinson KG, Lucey EC, Carver W, et al. Localization of a1(I) collagen mRNA in myocardium from the spontaneously hypertensive rat during the transition from compensated hypertrophy to failure. J Mol Cell Cardiol 1997; 29:2335-2344.
34. Bacharova L, Kyselovic J, Klimas J. QRS voltage-duration product in the identification of left ventricular hypertrophy in spontaneously hypertensive rats. Arq Bras Cardiol 2002; 79:143-148.
35. Ohtaka M. Stroke-prone SHR (SHRSP) as models for clinical and epidemiological studies on hypertension-related cardiac diseases in humans. Jpn Circ J 1980; 44:347-360.
36. Klimas J, Stankovicova T, Kyselovic J, Bacharova L. Prolonged QT interval is associated with blood pressure rather than left ventricular mass in spontaneously hypertensive rats. Clin Exp Hypert 2008; 30:475-485.
37. Ohtaka M. Vectorcardiographical and pathological approach to the relationship between cardiac hypertrophy and coronary arteriosclerosis in spontaneously hypertensive rats (SHR). Jpn Circ J 1980; 44:283-293.